ORGS · As filed with the SEC

Orgenesis cash flow statement, by quarter

The statement as Orgenesis presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Consolidated Statements of Cash Flows · USD thousands

USD thousands	Q4 2024^† 3 months ended Dec 31, 2024	Q3 2024^† 3 months ended Sep 30, 2024	Q2 2024^† 3 months ended Jun 30, 2024	Q1 2024 3 months ended Mar 31, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:
Profit or Loss	(20,376)^†	(9,266)^†	(9,366)^†	(10,005)
Adjustments required to reconcile net loss to net cash used in operating activities:
Stock-Based Compensation Expense	639^†	1,619^†	624^†	312
Convertible loans induced conversion expenses	0^†	0^†	—	—
Capital gain, net	(1,714)^†	—	—	—
Loss (gain) from deconsolidation of OBI, Korea and Belgium subsidiaries in 2024 (Octomera in 2023)	(4,546)^†	0^†	0^†	66
Depreciation Expense	461^†	538^†	706^†	381
Credit loss net related to OBI, Korea and Belgium subsidiaries	0^†	0^†	0^†	2,049
Amortization of Intangibles	17,646^†	—	—	—
Effect of exchange differences on inter-company balances	775^†	1,720^†	152^†	(200)
Net changes in operating leases	1,547^†	17^†	32^†	(8)
Change in Contingent consideration	(4,906)^†	81^†	—	—
Interest expense accrued on loans and convertible loans	172^†	174^†	555^†	637
Loss from extinguishment in connection with convertible loan restructuring	5,281^†	0^†	0^†	141
Changes in operating assets and liabilities:
Accounts receivable	121^†	79^†	4^†	(74)
Prepaid expenses, other accounts receivable	921^†	(251)^†	154^†	1,438
Inventory	0^†	0^†	—	—
Other assets	47^†	(3)^†	0^†	(1)
Related parties, net	(4)^†	3^†	—	—
Accounts payable	672^†	515^†	(2,968)^†	502
Change in Accrued Liabilities	26^†	(858)^†	(430)^†	442
Change in Accrued Liabilities	1,132^†	176^†	111^†	(119)
Deferred taxes, net	0^†	0^†	0^†	(2)
Net cash used in operating activities	(2,098)^†	(4,630)^†	(5,907)^†	(4,441)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property, plants and equipment	0^†	(58)^†	(1)^†	(204)
Net Cash from Investing Activities	0^†	0^†	0^†	139
Impact to cash resulting from deconsolidation of OBI, Korea and Belgium subsidiaries (see note 20)	(6)^†	0^†	0^†	(5)
Investment in long-term deposits	—	200^†	0^†	2
Net cash used in investing activities	292^†	142^†	(1)^†	(68)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of shares due to exercise of options and warrants (net of transaction costs)	0^†	28^†	168^†	2,360
Proceeds from Debt Issuance	0^†	0^†	0^†	75
Proceeds from receipts on account of shares to be allotted	—	—	—	155
Repayment of short and long-term debt	25^†	(106)^†	(112)^†	(33)
Proceeds from issuance of loans payable	1,390^†	3,723^†	640^†	307
Receipt from Germfree (see note 11a)	—	—	5,970^†	750
Proceeds from Debt Issuance	(16)^†	—	—	—
Receipt from Germfree (see note 13f)	0^†	—	—	—
Net cash provided by financing activities	1,399^†	4,435^†	6,511^†	3,614
NET CHANGE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH	(407)^†	(53)^†	603^†	(895)
Effect of Exchange Rate on Cash	(28)^†	19^†	(12)^†	(19)
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF YEAR	1,122	1,156	565	1,479
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT END OF YEAR	687	1,122	1,156	565
SUPPLEMENTAL NON-CASH FINANCING AND INVESTING ACTIVITIES
Exchange of convertible loans for equity	—	0^†	—	—
Net Cash from Operating Activities	0^†	214^†	—	—
Extinguishment in connection with convertible loan restructuring	—	—	—	141
CASH PAID DURING THE YEAR FOR:
Interest Expense	0^†	0^†	—	—

† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.